Skip to main content

Jade Biosciences, Inc.

JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001798749

No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Jade Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
56
+5 vs. Q2 2022
Shares held
27.0M
+1.20M (+4.7%) vs. Q2 2022
Total value
$447.4M
+$44.4M (+11.0%) vs. Q2 2022
New holders
9
21 more added
Sold out
4
18 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 56 institutions
Q1 2021: 0 institutionsQ2 2021: 18 institutionsQ3 2021: 41 institutionsQ4 2021: 47 institutionsQ1 2022: 46 institutionsQ2 2022: 51 institutionsQ3 2022: 56 institutionsQ4 2022: 70 institutionsQ1 2023: 66 institutionsQ2 2023: 60 institutionsQ3 2023: 58 institutionsQ4 2023: 64 institutionsQ1 2024: 81 institutionsQ2 2024: 81 institutionsQ3 2024: 75 institutionsQ4 2024: 80 institutionsQ1 2025: 82 institutionsQ2 2025: 75 institutionsQ3 2025: 78 institutionsQ4 2025: 105 institutionsQ1 2026: 120 institutionsQ2 2026: 153 institutions
Value heldQ3 2022: $447.4M
Q1 2021: $0Q2 2021: $454.4MQ3 2021: $452.6MQ4 2021: $301.6MQ1 2022: $475.5MQ2 2022: $403.0MQ3 2022: $447.4MQ4 2022: $802.9MQ1 2023: $524.1MQ2 2023: $488.3MQ3 2023: $386.3MQ4 2023: $637.8MQ1 2024: $841.5MQ2 2024: $45.1MQ3 2024: $57.8MQ4 2024: $79.9MQ1 2025: $79.6MQ2 2025: $315.1MQ3 2025: $272.9MQ4 2025: $726.3MQ1 2026: $700.3MQ2 2026: $1.62B
Institutions holding JBIO and their total value by quarter
QuarterHoldersValue
Q2 2026153$1.62B
Q1 2026120$700.3M
Q4 2025105$726.3M
Q3 202578$272.9M
Q2 202575$315.1M
Q1 202582$79.6M
Q4 202480$79.9M
Q3 202475$57.8M
Q2 202481$45.1M
Q1 202481$841.5M
Q4 202364$637.8M
Q3 202358$386.3M
Q2 202360$488.3M
Q1 202366$524.1M
Q4 202270$802.9M
Q3 202256$447.4M
Q2 202251$403.0M
Q1 202246$475.5M
Q4 202147$301.6M
Q3 202141$452.6M
Q2 202118$454.4M
Q1 20210$0

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q2 2022.

Institutions holding JBIO in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.8,263,982$137.0M2.92%00.0%Unchanged
Sofinnova Investments, Inc.3,758,686$62.3M3.96%00.0%Unchanged
Cormorant Asset Management, LP2,330,691$38.6M2.72%+600,000+34.7%Added
Atlas Venture Life Science Advisors, LLC2,327,909$38.6M4.26%−310,388−11.8%Reduced
Baker Bros. Advisors LP1,979,568$32.8M0.21%−90,442−4.4%Reduced
Citadel Advisors LLC1,615,578$26.8M0.03%+23,569+1.5%Added
TCG Crossover Management, LLC959,572$15.9M4.77%+70,000+7.9%Added
VR Adviser, LLC833,927$13.8M2.13%+243,519+41.2%Added
OrbiMed Advisors LLC795,000$13.2M0.26%+316,421+66.1%Added
BlackRock Inc.715,445$11.9M0.00%+10,077+1.4%Added
OUP Management Co., LLC603,762$10.0M15.59%00.0%Unchanged
FMR LLC525,060$8.71M0.00%−109,706−17.3%Reduced
Vanguard Group Inc466,232$7.73M0.00%+23,831+5.4%Added
Lynx1 Capital Management LP276,447$4.58M4.13%+84,882+44.3%Added
Ikarian Capital, LLC200,000$3.32M1.66%+200,000New
Fred Alger Management, LLC182,281$3.02M0.02%+9,575+5.5%Added
State Street Corp173,178$2.87M0.00%−5,376−3.0%Reduced
Geode Capital Management, LLC169,599$2.81M0.00%+3,437+2.1%Added
Ghost Tree Capital, LLC150,000$2.49M1.02%+150,000New
Millennium Management LLC83,630$1.39M0.00%+59,564+247.5%Added
Adage Capital Partners GP, L.L.C.80,000$1.33M0.00%−20,000−20.0%Reduced
Northern Trust Corp74,828$1.24M0.00%−1,312−1.7%Reduced
Skandinaviska Enskilda Banken AB (publ)56,431$936.0K0.01%00.0%Unchanged
Altium Capital Management LP51,000$846.0K0.32%+51,000New
Driehaus Capital Management LLC46,864$777.0K0.01%+46,864New
Boothbay Fund Management, LLC35,757$593.0K0.02%+35,757New
Nuveen Asset Management, LLC34,976$580.0K0.00%−3,812−9.8%Reduced
D. E. Shaw & Co., Inc.34,295$569.0K0.00%+34,295New
Bank of New York Mellon Corp27,546$457.0K0.00%+2,479+9.9%Added
Charles Schwab Investment Management Inc23,756$394.0K0.00%−80−0.3%Reduced
Parkwood LLC21,344$354.0K0.08%−11,070−34.2%Reduced
Rhumbline Advisers14,142$234.0K0.00%+949+7.2%Added
Bank of America Corp12,727$211.0K0.00%+10,696+526.6%Added
Ergoteles LLC10,574$175.0K0.01%−7,426−41.3%Reduced
New York State Common Retirement Fund7,686$127.0K0.00%+2,500+48.2%Added
JPMorgan Chase & Co6,824$113.0K0.00%+948+16.1%Added
Morgan Stanley4,764$78.0K0.00%−3,165−39.9%Reduced
American International Group, Inc.4,360$72.0K0.00%+63+1.5%Added
BNP Paribas Arbitrage, SA3,962$65.7K0.00%+3,962New
Deutsche Bank AG3,722$62.0K0.00%−620−14.3%Reduced
California State Teachers Retirement System3,625$60.0K0.00%−302−7.7%Reduced
Tower Research Capital LLC (TRC)3,449$57.0K0.00%+2,934+569.7%Added
STRS Ohio2,300$38.0K0.00%00.0%Unchanged
UBS Group AG1,612$26.0K0.00%+1,612New
Amalgamated Bank1,199$20.0K0.00%00.0%Unchanged
Russell Investments Group, Ltd.1,175$19.0K0.00%−881−42.9%Reduced
Legal & General Group Plc774$13.0K0.00%+360+87.0%Added
Ameritas Investment Partners, Inc.772$12.0K0.00%00.0%Unchanged
Citigroup Inc508$8.00K0.00%−570−52.9%Reduced
Royal Bank of Canada447$8.00K0.00%+395+759.6%Added
Barclays PLC389$6.00K0.00%−3,635−90.3%Reduced
China Universal Asset Management Co., Ltd.229$4.00K0.00%+229New
Daiwa Securities Group Inc.73$1.00K0.00%00.0%Unchanged
Credit Suisse AG50$1.00K0.00%+39+354.5%Added
Wells Fargo & Company28$00.00%−90−76.3%Reduced
Ellevest, Inc.1$00.00%−12−92.3%Reduced
Sectoral Asset Management Inc0$00.00%−196,038−100.0%Sold out
Chicago Partners Investment Group LLC0$00.00%−10,163−100.0%Sold out
Jane Street Group, LLC0$00.00%−11,717−100.0%Sold out
FinTrust Capital Advisors, LLC0$00.00%−82−100.0%Sold out